Asthma Treatment Algorithm
To successfully treat asthma, you must first classify it and then be familiar with step therapy. For this assignment and in this course, we will focus on patients 12 years and older. Complete the blanks in the following table to create an algorithm for asthma care using your textbook as well as GINA guidelines .
| Step | Asthma Classification | Asthma symptoms and frequency as noted in textbook | Controller and Preferred Reliever:
Don't use plagiarized sources. Get Your Custom Essay on
Asthma Treatment Algorithm
Just from $13/Page
(Drug Class and frequency if provided from GINA guidelines) |
Controller and Alternative Reliever:
(Drug Class and frequency if provided from GINA guidelines) |
|
| Step 1 | Click or tap here to enter text. | Daytime symptoms | Click or tap here to enter text. | Drug class: Click or tap here to enter text.
Frequency: Click or tap here to enter text.
|
Drug class: Click or tap here to enter text.
Frequency: Click or tap here to enter text. |
| Nighttime awakenings | Click or tap here to enter text. | ||||
| Step 2 | Click or tap here to enter text. | Daytime symptoms | Click or tap here to enter text.
|
Drug class: Click or tap here to enter text. | |
| Nighttime awakenings | Click or tap here to enter text. | ||||
| Step 3 | Click or tap here to enter text.
|
Daytime symptoms | Click or tap here to enter text. | Drug class:
Click or tap here to enter text.
|
Drug class: Click or tap here to enter text.
|
| Nighttime awakenings | Click or tap here to enter text. | ||||
| Step
4-5 |
Click or tap here to enter text. | Daytime symptoms | Click or tap here to enter text. | Step 4:
Drug class: Click or tap here to enter text. |
Drug class: Click or tap here to enter text.
|
| Nighttime awakenings | Click or tap here to enter text. | Step 5:
Drug class: Click or tap here to enter text. Refer for: Click or tap here to enter text. |
No change. |
Starting treatment:
Complete this section using the GINA guidelines provided.
First Assess:
Click or tap here to enter text.
Click or tap here to enter text.
Click or tap here to enter text.
Click or tap here to enter text.
Click or tap here to enter text.
1. Click or tap here to enter text.
Fill in the blank:
1. Using Click or tap here to enter text.as reliever reduces the risk of Click or tap here to enter text.compared with using a Click or tap here to enter text.reliever.
2. Before considering a regimen with a Click or tap here to enter text.reliever, check if the patient is likely to be adherent with Click or tap here to enter text..
Dosing: Low, Medium, High
Low dose ICS provides most of the clinical benefit for most patients. However, ICS responsiveness varies between patients, so some patients may need medium dose ICS if asthma is uncontrolled despite good adherence and correct inhaler technique with low dose ICS. High dose ICS is needed by very few patients, and its long-term use is associated with an increased risk of local and systemic side-effects.
| Adults and adolescents Inhaled corticosteroid | Total daily (24 hour) ICS dose (mcg) | ||
| Low | Medium | High | |
| BDP (pMDI, HFA) | 200-500 | >500-1000 | >1000 |
| BDP (DPI or pMDI, extrafine particle, HFA) | 100-200 | >200-400 | >400 |
| Budesonide (DPI or PMDI, HFA) | Click or tap here to enter text. | Click or tap here to enter text. | Click or tap here to enter text. |
| Ciclesonide (pMDI, extrafine particle, HFA) | 80-160 | >160-320 | >320 |
| Fluticasone furoate | Click or tap here to enter text. | Click or tap here to enter text. | |
| Fluticasone propionate (DPI) | Click or tap here to enter text. | Click or tap here to enter text. | Click or tap here to enter text. |
| Fluticasone propionate (pMDI, HFA) | Click or tap here to enter text. | Click or tap here to enter text. | Click or tap here to enter text. |
| Mometasone furoate (pMDI, HFA) | 200-400 | 400 |
Treating Modifiable Risk Factors
Exacerbation risk can be minimized by optimizing asthma medications and by identifying and treating modifiable risk factors. List the six modifiable risk factors identified in the GINA guidelines that show consistent high-quality evidence.
Click or tap here to enter text.
Click or tap here to enter text.
Click or tap here to enter text.
Click or tap here to enter text.
Click or tap here to enter text.
1. Click or tap here to enter text.
Non-Pharmacological Strategies and Interventions
In addition to medications, other therapies and strategies may be considered when relevant, to assist in symptom control and risk reduction. List the examples the GINA guidelines provide.